Mishra S, Undrovinas NA, Maltsev VA, Reznikov V, Sabbah HN, Undrovinas A. Post-transcriptional silencing of SCN1B and SCN2B genes modulates late sodium current in cardiac myocytes from normal dogs and dogs with chronic heart failure. Am J Physiol Heart Circ Physiol 301: H1596 -H1605, 2011. First published June 24, 2011 doi:10.1152/ajpheart.00948.2009.-The emerging paradigm for Na ϩ current in heart failure (HF) is that its transient component (INaT) responsible for the action potential (AP) upstroke is decreased, whereas the late component (INaL) involved in AP plateau is augmented. Here we tested whether Nav1-and Nav2-subunits can modulate INaL parameters in normal and failing ventricular cardiomyocytes (VCMs). Chronic HF was produced in nine dogs by multiple sequential coronary artery microembolizations, and six dogs served as a control. INa and APs were measured by the whole cell and perforated patch-clamp in freshly isolated and cultured VCMs, respectively. INaL was augmented with slower decay in HF VCMs compared with normal heart VCMs, and these properties remained unchanged within 5 days of culture. Posttranscriptional silencing SCN1B and SCN2B were achieved by virally delivered short interfering RNA (siRNA) specific to Nav1 and Nav2. The delivery and efficiency of siRNA were evaluated by green fluorescent protein expression, by the real-time RT-PCR, and Western blots, respectively. Five days after infection, the levels of mRNA and protein for Nav1 and Nav2 were reduced by Ͼ80%, but mRNA and protein of Nav1.5, as well as INaT, remained unchanged in HF VCMs. Nav1-siRNA reduced INaL density and accelerated INaL two-exponential decay, whereas Nav2-siRNA produced an opposite effect in VCMs from both normal and failing hearts. Physiological importance of the discovered INaL modulation to affect AP shape and duration was illustrated both experimentally and by numerical simulations of a VCM excitationcontraction coupling model. We conclude that in myocytes of normal and failing dog hearts Nav1 and Nav2 exhibit oppositely directed modulation of INaL. action potential; in silico simulation THE EMERGING PARADIGM FOR Na ϩ current (I Na ) in chronic heart failure (HF) is that its transient component (I NaT ) responsible for the action potential (AP) upstroke and excitation propagation is decreased, whereas the late component (I NaL ) involved in AP plateau is augmented (21,23,25,42,45,48). Molecular mechanisms of these HF-related I Na alterations are still understudied. Numerous studies indicate a possible role of Na v  auxiliary subunits to modulate Na ϩ channel (NaCh) expression and function (27), but implications of Na v  in I NaL modulation have not been studied in detail, especially in HF. Our previous studies in a canine chronic HF model showed that the protein level of the main NaCh isoform expressed in the heart, Na v 1.5, underlying I NaL (18), is reduced but remains unchanged for Na v  1 -and Na v  2 -subunits, making these -subunits relatively upregulated (48). Thus an intriguing possibility...